Cargando…
PD-1抑制剂治疗复发或难治性经典型霍奇金淋巴瘤的疗效和安全性分析
OBJECTIVE: This retrospective, single-center study aimed to evaluate the efficacy and safety of programmed death-1（PD-1）inhibitors, either as monotherapy or in combination with chemotherapy, in the management of relapse/refractory classical Hodgkin's lymphoma（R/R cHL）. METHODS: A total of 35 pa...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509629/ https://www.ncbi.nlm.nih.gov/pubmed/37749034 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.07.005 |